As members of GLIDE’s HIV & Hep C Harm Reduction Programs, the Hepatitis C navigators and I get the pleasure of being part of the...
Continue Reading →
How many people have hepatitis C in San Francisco? End Hep C SF estimates that approximately 22,000 residents of San Francisco have antibodies to HCV...
Continue Reading →
Katie Burk, MPH, is the viral hepatitis coordinator at the San Francisco Department of Public Health and is on the coordinating committee of End Hep C...
Continue Reading →
Eliminating Hepatitis C in San Francisco: Why Now? San Francisco is profoundly impacted by the hepatitis C virus (HCV), a chronic liver disease easily transmitted...
Continue Reading →
An article was published in The Economist examining our multi-stakeholder / multi-sector strategy for HCV elimination in San Francisco. Read the full article here. View...
Continue Reading →
An article was just published in The Bay Area Reporter, “13,000 San Franciscans have hep C, report says” “New estimates suggest that nearly 13,000 people...
Continue Reading →
The introduction of Hepatitis C Direct Acting Agents (DAA’s) has significantly altered the treatment paradigm.  The combination of improved sustained viral response (SVR) rates, minimal...
Continue Reading →
NASTAD Highlights End Hep C SF In Their Chair’s Challenge...
Continue Reading →
One autumn day I brought my children to work with me in the Tenderloin. We took the 38R down O’Farrell and jumped off between Jones...
Continue Reading →
  Hepatitis C is a chronic condition for which a cure exists, but at a cost that is so high it often creates barriers to...
Continue Reading →